Reaction

Respiratory Disorder Neonatal reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 1,571 reports · 39 co-occurring drugs

As of the last recalculation, Respiratory Disorder Neonatal appears in 1,571 FAERS reports alongside 39 co-occurring drug terms. The strongest observed disproportionality signal is MISOPROSTOL (PRR 70.2).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.

Drug	Co-reports	PRR	ROR
Misoprostol	50	70.2	70.6
Venlafaxine	208	44.2	44.3
Ampicillin	27	43.9	44.1
Ampicillin Sodium	27	43.9	44.1
Citalopram Hydrobromide	201	28.3	28.4
Sertraline	206	26.6	26.7
Lamotirigine	129	25.9	25.9
Lamotrigine Extended-Release	129	25.9	25.9
Lamotrigine Chewable Dispersible	129	25.9	25.9
Venlafaxine Hydrochloride	222	25.7	25.8
Dimenhydrinate	18	22.6	22.7
Citalopram	204	22.6	22.6
Quetiapine	242	19.5	19.5
Escitslopram	70	16.6	16.7
Dalteparin Sodium	13	16.4	16.4
Lamotrigine	146	16.1	16.1
Progesterone	27	15.9	15.9
Clobazam	28	15.5	15.5
Nicotine Polacrilex Mini	17	15.2	15.2
Nicotine Polarilex	17	15.2	15.2
Zonisamide	16	14.5	14.5
Escitalopram Oxalate	72	13.7	13.7
Phenytoin	19	12.2	12.2
Zidovudine	12	12.0	12.0
Dronabinol	7	11.6	11.6
Levetiracetam In Sodium Chloride	65	11.6	11.6
Levetiracetam Oral	65	11.6	11.6
Levetiracetam Injection	65	11.5	11.6
Levothyroxine Sodium Anhydrous	82	11.4	11.4
Atropine	7	11.2	11.2
Gentamicin Sulfate	13	11.0	11.0
Tobramycin Sulfate	9	9.7	9.7
Duloxetine	48	9.4	9.4
Tobramycin Solution	8	8.9	8.9
Levodopa	8	8.8	8.8
Levetiracetam	81	8.4	8.4
Buprenorphine Hydrochloride, Naloxone Hydrochloride	11	6.1	6.1
Nicotine Polacrilex	17	5.9	5.9
Nicotine	17	5.6	5.6

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.